TMAPX
Price
$55.18
Change
-$0.34 (-0.61%)
Updated
Aug 15 closing price
Net Assets
5.47B
VIMSX
Price
$78.00
Change
-$0.19 (-0.24%)
Updated
Aug 15 closing price
Net Assets
196.76B
Interact to see
Advertisement

TMAPX vs VIMSX

Header iconTMAPX vs VIMSX Comparison
Open Charts TMAPX vs VIMSXBanner chart's image
Touchstone Mid Cap A
Price$55.18
Change-$0.34 (-0.61%)
VolumeN/A
Net Assets5.47B
Vanguard Mid Cap Index Investor
Price$78.00
Change-$0.19 (-0.24%)
VolumeN/A
Net Assets196.76B
TMAPX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TMAPX vs. VIMSX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMAPX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 197B vs. TMAPX (5.47B). VIMSX pays higher dividends than TMAPX: VIMSX (1.37) vs TMAPX (0.04). TMAPX was incepted earlier than VIMSX: TMAPX (18 years) vs VIMSX (27 years). TMAPX (1.17) is less costly to investors than VIMSX (0.17). TMAPX is a more actively managed with annual turnover of: 18.00 vs. VIMSX (16.00). TMAPX has a lower initial minimum investment than VIMSX: TMAPX (2500) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 14.59 vs. TMAPX (2.53). VIMSX return over 5 years is better than : 62.56 vs. TMAPX (42.58).
TMAPXVIMSXTMAPX / VIMSX
Total Expense Ratio1.170.17688%
Annual Report Gross Expense Ratio1.170.17688%
Fund Existence18 years27 years-
Gain YTD2.5308.55530%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.47B197B3%
Annual Yield % from dividends0.041.373%
Returns for 1 year2.5314.5917%
Returns for 3 years22.4926.7084%
Returns for 5 years42.5862.5668%
Returns for 10 years118.40125.6494%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROKU90.292.78
+3.18%
Roku
NNNN50.910.77
+1.54%
Anbio Biotechnology
ABOS1.420.02
+1.43%
Acumen Pharmaceuticals
KIDS19.190.06
+0.31%
OrthoPediatrics Corp
ASNS0.51-0.11
-17.94%
Actelis Networks